Adaptive designs are clinical trials that allow for prospectively planned modifications to one or more aspects of the design based on accumulating data from subjects in the trial and can provide a number of advantages over non-adaptive designs.  During this meeting we will hear about adaptive sample allocation for phase II/III designs, a new CONSORT extension reporting guideline for adaptive designs, regulatory aspects and case studies.